Oncogene-­-Induced Secretion of Extracellular Matrix Proteins in Squamous Cell Carcinoma of the Skin

Overview

  • Study type

    Observational
  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 11-006375
    Sponsor Protocol Number: 11-006375

About this study

The purpose of this study is:

Define a set of differentially regulated secreted proteins in human cancer cells across all stages of cancer progression

  • Identify a set of 32 genes (including housekeeping genes) that encode for secreted proteins that correlate with disease progression using a bioinformatics approach
  • Design probe sets for RT-PCR and run a pilot study both on FFPE and fresh tissue
  • If the pilot is successful, expand the data set to an n of 100. Include SCCs of various differentiation and anatomical location. Include SCCs from transplant patients.

Correlate the results of the RT-PCR panel to the biological behavior of the tumor

  • The following variables will be examined:
    • Differentiation
    • Ability to metastasize
    • Response to therapy

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

  1. All tissue collected will be from sun-exposed sites
  2. All tissue will be from adult patients (18 years and older)

Exclusion Criteria:

  1. Children (below 18 years of age) are excluded from the study

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Alexander Meves, M.D.

Contact us for the latest status

Contact information:

Jennifer Winters

Winters.Jennifer@mayo.edu

.
CLS-20318065

Mayo Clinic Footer